Updated Jul 16, 2026
STARKS DANIEL J has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $2.01M.
Daniel J. Starks is an executive associated with Abbott Laboratories, a global healthcare company known for its pharmaceuticals, medical devices, and nutritional products. He has held various roles within the company, contributing to its strategic direction and operational success.
| Role | Insider |
|---|---|
| Notability | 75/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-28 | ABT | ABBOTT LABORATORIES | P — Open-market purchase | 10.0K | $92.65 | $927K |
| 2026-04-28 | ABT | ABBOTT LABORATORIES | A — Grant or award | 2.3K | $0.00 | |
| 2026-02-06 | ABT | ABBOTT LABORATORIES | P — Open-market purchase | 5.0K | $108.33 | $545K |
| 2026-02-06 | ABT | ABBOTT LABORATORIES | P — Open-market purchase | 5.0K | $109.14 | $542K |
Daniel J. Starks is an executive associated with Abbott Laboratories, a global healthcare company known for its pharmaceuticals, medical devices, and nutritional products. He has held various roles within the company, contributing to its strategic direction and operational success.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 3 open-market purchases ($2.01M) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live STARKS DANIEL J profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.